Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
Alan J. Garber(Baylor College of Medicine), Guillermo E. Umpierrez(Emory University), Leigh Perreault(Colorado School of Public Health), Jeffrey R. Garber(Harvard Vanguard Medical Associates), Irl B. Hirsch(University of Washington), Paul D. Rosenblit(University of California, Irvine Medical Center), George Grunberger(Grunberger Diabetes Institute), Yehuda Handelsman(Tarzana Treatment Centers), Janet B. McGill(Washington University in St. Louis), Martin J. Abrahamson(Beth Israel Deaconess Medical Center), Paul S. Jellinger(University of Miami), Lawrence Blonde(Ochsner Medical Center), Jeffrey I. Mechanick(Mount Sinai Hospital), Ralph A. DeFronzo(The University of Texas at San Antonio Health Science Center), Michael A. Bush(Cedars-Sinai Medical Center), W. Timothy Garvey(University of Alabama at Birmingham), Joshua I. Barzilay(Kaiser Permanente), Daniel Einhorn(Diabetes & Endocrine Associates), Susan L. Samson(Jacksonville College)
Cited by 603
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
|The Journal of Clinical Endocrinology & Metabolism|2002|2.1k
Hyperglycemic Crises in Adult Patients With Diabetes
|Diabetes Care|2009|2k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k